N
Navio Systems
Commerce and digital rewards solutions for web and mobile digital content
About Navio Systems
Navio Systems operated as a specialized healthcare technology firm centered on the oncology sector. The company was founded by Todd Meyerrose, an entrepreneur and investor with a deep background in biotechnology and precision medicine. Dr. Meyerrose's journey is rooted in science and innovation; he holds PhDs in Molecular Cell Biology and Craniofacial Biology and was the co-founder of Lexent Bio, a precision oncology company acquired by Foundation Medicine, a subsidiary of Roche, in 2020. This experience in developing liquid biopsy platforms for cancer diagnostics directly informed the mission of Navio Systems.
Read full description
The business was focused on improving the treatment journey for cancer patients. It developed a cancer support platform designed to enhance patient engagement and adherence to complex treatment schedules. The platform provided patients with personalized treatment information, schedules, and tools to record their experiences and feelings, aiming to create a better-managed and more informed treatment process. For healthcare providers, the service offered access to patient treatment timelines, which could save time and lead to an improved patient experience. The company's business model was based on providing this Software-as-a-Service (SaaS) platform to participants in the cancer care ecosystem. Despite its targeted approach and the founder's relevant expertise, Navio Systems ceased operations. The venture-backed company filed for bankruptcy and liquidation in April 2024.
Latest news
Press, funding announcements and product moves mentioning Navio Systems.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Nov 2005 | $25M | $102M | VantagePoint Capital Partners · WK Technology Fund | — |
Growth signals
Latest recorded traffic for Navio Systems is 70 monthly website visits, down 22.2% over the last three months. Navio Systems's team grew 0% over the past year.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
- WFWK Technology Fund
VantagePoint Capital Partners
Other known investors1 additional known investor
Toby Coppel
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Navio Systems on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Navio Systems’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.